Atopic Dermatitis MarketSize and Trends

The global atopic dermatitis market was valued at US$ 7,795.3 Mn in 2021 and is forecast to reach a value of US$ 14,941.2 Mn by 2028 at a CAGR of 9.7% between 2022 and 2028. The global atopic dermatitis market is experiencing strong growth due to the increasing prevalence of atopic dermatitis and increasing awareness among people about atopic dermatitis. Moreover, increase in focus on the development of novel therapeutics and outbreak of COVID-19 is expected to boost the growth of the market. However, factors such as adverse effects of certain therapeutic drugs and treatment cost variations limit patient access are expected to hamper the market growth.

Global Atopic Dermatitis Market Trends:

Increase in demand for safe/effective treatment is a recent trend

With the rise in prevalence of atopic dermatitis, the demand for safe and effective AD treatment. As a result, players in the market are focusing on developing and launching novel therapeutics in the market. Left untreated, eczema can lead to severe symptoms and increased risk of developing secondary infections. In severe long-term cases, untreated childhood eczema may interfere with growth and development.

Increase in use of atopic dermatitis drugs is another trend

Topical corticosteroids have been the mainstay of treatment for atopic dermatitis over the years. Corticosteroids are used as pain relief medicines for inflammation in the body. Corticosteroids are known to reduce itching, redness, swelling, and allergic reactions. Clinical trials have also shown that topical corticosteroids are safe and effective to treat atopic dermatitis flare-ups.

Global Atopic Dermatitis Market Segmentation:

The global atopic dermatitis market is segmented into Drug Class, Type of Administration, Prescription Type, and Geography.

Based on Drug Class, the market is segmented into Corticosteroids, Emollients/Moisturizers, IL-4 & PDE4 Inhibitors, Calcineurin Inhibitors Antibiotics, and Other Drug Classes. Out of which, Corticosteroids Segment is expected to dominate the atopic dermatitis market during the forecast period and this is attributed to the increase in usage of corticosteroids. Topical corticosteroids have been the mainstay of treatment for atopic dermatitis.

Emollients/Moisturizers Segment is also expected to witness significant growth in the near future and this is owing to the increase in awareness among people about atopic dermatitis.

Based on Type of Administration, the market is segmented into Topical, Oral, and Injectable. Out of which, Topical Segment is expected to dominate the market over the forecast period and this is attributed to the increase in adoption of topical AD treatments. Topical application remains the primary method for the atopic dermatitis management.

Oral Segment is also expected to witness significant growth in the near future and this is owing to the rise in cases of atopic dermatitis. For severe cases, doctors may prescribe oral corticosteroids, such as prednisone, for the atopic dermatitis management.

Based on Prescription Type, the atopic dermatitis market is segmented into Over-the-counter (OTC) and Prescription. Of which, Over-the-counter (OTC) Segment is expected to dominate the market over the forecast period and this is attributed to the increase in usage of over-the-counter (OTC) drugs to treat atopic dermatitis. Over-the-counter medications that can help prevent flares and assist with sleep are widely available worldwide.

Based on geography, the global atopic dermatitis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the increasing incidence of atopic dermatitis, increasing awareness among people about atopic dermatitis, and government campaigns to raise awareness in the region. For instance, atopic dermatitis (eczema) is the condition that causes dry, itchy, and inflamed skin. According to the Asthma and Allergy Foundation of America, the most common form of eczema, AD (atopic dermatitis) leads to significant emotional burden in addition to pain, physical discomfort, and sleep disturbance for 16.5 million adults in the United States.

Europe is also expected to witness robust growth in the global atopic dermatitis market due to the growing prevalence of atopic dermatitis and strategic initiatives undertaken by the government and market players in the region. For instance, according to the European Medicines Agency (EMA), European Union, In Europe, it is estimated that up to 7% of adults have atopic dermatitis and the proportion of adults with the moderate to severe form of the disease is around 30%. Moreover, one in four adults with the disease report its onset in adulthood. This in turn is expected to drive growth of the atopic dermatitis market in the region (Europe).

Figure 1. Global Atopic Dermatitis Market Share (%), by Region, 2021